Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Long QT Syndrome: full-pipeline trial registry
3 of 8 indexed Long QT Syndrome trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Long QT Syndrome: 8 US clinical trials tracked, 3 recruiting.
Long QT Syndrome is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Gilead Sciences, running 1 of these trials.
Enrollment posture brief
Registry condition long-qt-syndrome
OPEN 3 | RECR 38% | LATE 1 | EARLY 1 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
Long QT Syndrome lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Long QT Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Long QT Syndrome is recruiting below its size-band peers.
3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Long QT Syndrome trials is spread across many organizations.
Gilead Sciences accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Long QT Syndrome trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 8 trials that report a genuine target (sentinel values excluded). 6 of those (75%) plan for fewer than 100 participants.
-
Long QT Syndrome splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Comparing Direct vs Indirect Methods for Cascade Screening
University of Maryland, Baltimore
NCT05348564
Continuous Versus Intermittent cARdiac Electrical moNitorinG
Washington University School of Medicine
NCT04336644
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Medical College of Wisconsin
NCT03775954
Exercise in Genetic Cardiovascular Conditions
Yale University
NCT02549664
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Indiana University
NCT04675788
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
Gilead Sciences
NCT02365532
Fetal and Neonatal Magnetophysiology
University of Wisconsin, Madison
NCT01903564
Long QT Syndrome and Sleep Apnea
The Cleveland Clinic
NCT03678311
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Long QT Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Long QT Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Long QT Syndrome page
8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Long QT Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Gilead Sciences sponsors the most Long QT Syndrome trials on record, review their full trial history before evaluating a specific study. See Gilead Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Long QT Syndrome condition card totals 8 registered trials; most-linked intervention fetal echocardiography; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.